ATE457168T1 - Transdermales therapeutisches system von gestoden - Google Patents

Transdermales therapeutisches system von gestoden

Info

Publication number
ATE457168T1
ATE457168T1 AT04078365T AT04078365T ATE457168T1 AT E457168 T1 ATE457168 T1 AT E457168T1 AT 04078365 T AT04078365 T AT 04078365T AT 04078365 T AT04078365 T AT 04078365T AT E457168 T1 ATE457168 T1 AT E457168T1
Authority
AT
Austria
Prior art keywords
gestode
therapeutic system
transdermal therapeutic
transdermal
therapeutic
Prior art date
Application number
AT04078365T
Other languages
English (en)
Inventor
Thomas Langguth
Stefan Bracht
Michael Dittgen
Petra Huber
Drik Schenk
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34924031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE457168(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of ATE457168T1 publication Critical patent/ATE457168T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04078365T 2003-12-12 2004-12-10 Transdermales therapeutisches system von gestoden ATE457168T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03078881 2003-12-12

Publications (1)

Publication Number Publication Date
ATE457168T1 true ATE457168T1 (de) 2010-02-15

Family

ID=34924031

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04078365T ATE457168T1 (de) 2003-12-12 2004-12-10 Transdermales therapeutisches system von gestoden

Country Status (24)

Country Link
EP (2) EP1541137B1 (de)
CN (1) CN101843603B (de)
AR (1) AR046762A1 (de)
AT (1) ATE457168T1 (de)
CR (1) CR8465A (de)
CY (2) CY1110637T1 (de)
DE (1) DE602004025444D1 (de)
DK (2) DK1541137T3 (de)
ES (2) ES2340925T3 (de)
GT (1) GT200400262A (de)
HK (2) HK1074801A1 (de)
HN (1) HN2004000526A (de)
HR (2) HRP20100254T1 (de)
JO (1) JO2606B1 (de)
ME (1) ME01069B (de)
MY (2) MY144053A (de)
PE (1) PE20051035A1 (de)
PL (2) PL2138169T3 (de)
PT (2) PT2138169E (de)
RS (2) RS51260B (de)
SI (2) SI2138169T1 (de)
SV (1) SV2006001970A (de)
TW (1) TWI257299B (de)
UA (1) UA89766C2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1594483B1 (de) 2003-02-21 2006-07-19 Schering AG Uv-stabiles transdermales pflaster
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
ES2795455T3 (es) 2008-10-08 2020-11-23 Agile Therapeutics Inc Suministro transdérmico
WO2010042610A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
EP2343963B1 (de) 2008-10-08 2019-04-10 Agile Therapeutics, Inc. Transdermale freisetzung
US9198920B2 (en) 2009-03-27 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
CN103189064B (zh) 2010-09-06 2015-08-12 拜耳知识产权有限责任公司 具有高药物释放的低剂量透皮贴剂
AU2015203180B2 (en) * 2010-09-06 2016-06-30 Bayer Intellectual Property Gmbh Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
NZ627242A (en) * 2012-01-27 2016-08-26 Agile Therapeutics Inc Transdermal hormone delivery

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081537A (en) 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof
WO1990004397A1 (de) * 1988-10-27 1990-05-03 Schering Aktiengesellschaft Berlin Und Bergkamen Mittel zur transdermalen applikation enthaltend gestoden
PT99338A (pt) 1990-10-29 1992-10-30 Alza Corp Processo para a preparacao de composicoes de farmacos anticoncepcionais administradas transdermicamente contendo uma mistura dum estrogeno e gestodeno e dispositivos para a sua administracao transdermica
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4329242A1 (de) * 1993-08-26 1995-03-02 Schering Ag Mittel zur transdermalen Applikation enthaltend Gestodenester
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
US5762956A (en) 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
PT1242012E (pt) 1999-11-24 2010-03-31 Agile Therapeutics Inc Sistema e processo melhorado de libertação transdérmica de contraceptivo
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
AU2002235155A1 (en) 2000-12-05 2002-06-18 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems

Also Published As

Publication number Publication date
PE20051035A1 (es) 2006-02-08
MY144053A (en) 2011-08-15
CN101843603A (zh) 2010-09-29
EP2138169A3 (de) 2011-04-06
SV2006001970A (es) 2006-02-16
MY152750A (en) 2014-11-28
PL1541137T3 (pl) 2010-07-30
ME01069B (de) 2012-10-20
TW200528073A (en) 2005-09-01
HK1132682A1 (en) 2010-03-05
PL2138169T3 (pl) 2014-04-30
DK1541137T3 (da) 2010-04-26
CN101843603B (zh) 2012-06-27
CY1110637T1 (el) 2015-04-29
EP2138169A2 (de) 2009-12-30
SI2138169T1 (sl) 2014-03-31
CR8465A (es) 2007-06-06
EP2138169B1 (de) 2013-11-06
EP1541137B1 (de) 2010-02-10
TWI257299B (en) 2006-07-01
RS53182B (en) 2014-06-30
ES2340925T3 (es) 2010-06-11
HK1074801A1 (en) 2005-11-25
SI1541137T1 (sl) 2010-06-30
DE602004025444D1 (de) 2010-03-25
HN2004000526A (es) 2010-02-01
JO2606B1 (en) 2011-11-01
UA89766C2 (en) 2010-03-10
AR046762A1 (es) 2005-12-21
PT2138169E (pt) 2014-02-17
HRP20100254T1 (hr) 2010-06-30
EP1541137A3 (de) 2005-11-16
DK2138169T3 (da) 2013-11-18
ES2445690T3 (es) 2014-03-04
EP1541137A2 (de) 2005-06-15
PT1541137E (pt) 2010-05-17
RS51260B (sr) 2010-12-31
HRP20140077T1 (hr) 2014-02-28
CY1115064T1 (el) 2016-12-14
GT200400262A (es) 2005-10-31

Similar Documents

Publication Publication Date Title
CY2016035I2 (el) Θεραπευτικη χρηση αντισωματων anti-cs1
AT8585U3 (de) Transdermal-pflaster zum verabreichen von fentanyl
NO20052914D0 (no) Terapeutiske forbindelser
DE60322582D1 (de) Oberflächenbehandlung von medizinischem gerät
DE60333294D1 (de) Kontrollierte verabreichung von arzneien
MA28802B1 (fr) Utilisations therapeutiques d'inhibiteurs de rtp801
IS8913A (is) Afleiður 4-tetrazólýl-4-fenýlpiperidíns til þess að meðhöndla verk
DE602005012267D1 (de) N von geräten
IS7825A (is) Meðferðarfræðileg meðhöndlun
NO20050689L (no) Terapeutisk anvendelse
ATE401870T1 (de) Transdermales therapeutisches system zur verabreichung von analgetika
ATE457168T1 (de) Transdermales therapeutisches system von gestoden
DK1597171T3 (da) Terapeutisk mikroskum
ATA13602003A (de) Therapeutisches behandlungsgerät
DE602004004262D1 (de) Ultraschallbehandlung von gewebematrices
DE60321572D1 (de) Transdermales arzneimittelverabreichungssystem
DK1596876T3 (da) Anvendelse af pvp-iod liposomer til behandling af akne
DE602004011679D1 (de) Behandelung von Störungen
ATE499348T1 (de) Stabiler polymorph von bifeprunoxmesilat
DE602004022100D1 (de) Stimulationshilfe
ATE410417T1 (de) Kristallmodifikationen von triazinylaminostilbenen
DE60326437D1 (de) Therapeutische verwendung von sapogeninen
DE60308390D1 (de) Behandlung von Hyperurikämie
ITPN20020048A1 (it) Impianto per idromassaggio
SE0200450D0 (sv) Therapeutic agents

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1541137

Country of ref document: EP